4 Midcap DII Backed High Margin Stocks to Watch for Future Multibagger Potential: MCX, Oil India, Sona BLW and Ajanta Pharma
- November 2, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
MCX Rs 3,188.80. Oil India Rs 454. Sona BLW Rs 890.50. Ajanta Pharma Rs 3,508.80. Market caps from Rs 44,167 crore to Rs 82,566 crore. Data as of 30 Oct 2026.
Quick Answer
MCX, Oil India, Sona BLW and Ajanta Pharma are the 4 picks in this DII backed high margin stocks watchlist, with market caps between Rs 44,167 crore and Rs 82,566 crore. MCX stands out for the highest return on equity at 46.75%, while Oil India offers the lowest PE of the group at 7.58. PE ratios run from 7.58 to 84.50, so compare each one with its industry PE before investing. All figures are as of 30 October 2026.
DII backed high margin stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. MCX, Oil India, Sona BLW and Ajanta Pharma meet that test, with market caps from Rs 44,167 crore to Rs 82,566 crore and MCX offering the highest return on equity at 46.75%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a domestic institutional holding of at least 20 per cent and an operating margin of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a domestic institutional holding of at least 20 per cent and an operating margin of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening DII backed high margin stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are DII Backed High Margin Stocks and Why Do They Attract Multibagger Interest?
DII backed high margin stocks are shares of mid sized companies in which domestic funds, insurers and mutual funds together own at least twenty per cent of the business and which keep at least twenty paise of operating profit from every rupee of sales. The four here cover commodity exchange services, oil and gas exploration, pharmaceuticals and auto components.
Domestic funds invest money from Indian savers and study companies in depth, so a large DII stake in a company with a high margin shows steady local trust in its pricing power. For DII backed high margin stocks, both FY26 and the latest quarter showed growth. Whichever way you read DII backed high margin stocks, the common thread is rising profit backed by complete financial data. With DII backed high margin stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for DII backed high margin stocks are complete. Read each company’s latest results and exchange filings before acting on DII backed high margin stocks.
DII Backed High Margin Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 30 October 2026. Oil India has the lowest PE of the group at 7.58, while MCX posts the highest return on equity at 46.75%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Multi Commodity Exchange of India | 3,188.80 | 82,566 | 53.55 | 42.17 | 46.75% | 0.00 | 1,762.10 to 3,481.40 |
| Oil India | 454 | 72,288 | 7.58 | 7.16 | 11.41% | 0.65 | 395.60 to 531.00 |
| Sona BLW Precision Forgings | 890.50 | 57,970 | 84.50 | 37.33 | 10.70% | 0.07 | 434.40 to 890.50 |
| Ajanta Pharma | 3,508.80 | 44,167 | 38.92 | 36.35 | 23.33% | 0.06 | 2,380.20 to 3,796.00 |
MCX: 74.55% Profit CAGR Since FY22
MCX is India’s leading commodity derivatives exchange, where gold, silver, crude oil, natural gas and base metals contracts are traded. It reported FY26 revenue of Rs 2,429.05 crore, up 100.94% year on year, and net profit of Rs 1,331.55 crore, up 137.76%. Net profit has compounded at 74.55% a year since FY22, while revenue has grown 53.87% a year. Operating margin was 76.83% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.
In the June 2026 quarter, revenue rose 85.25% to Rs 751.79 crore and net profit grew 103.47% to Rs 413.44 crore. The share price has gained 720.06% over five years and 69.44% over the past year. Foreign investors raised their holding from 21.69% in June 2025 to 29.84% in June 2026. The stock trades at a PE of 53.55 against an industry PE of 42.17, with a return on equity of 46.75%.
Oil India: Quarterly Profit Up 96.77%
Oil India is a government-owned oil and gas exploration and production company with operations in Assam, Rajasthan and overseas blocks. It reported FY26 revenue of Rs 35,877.28 crore, up 4.97% year on year, and net profit of Rs 7,550.67 crore, up 7.26%. Revenue has compounded at 7.32% a year since FY22. Operating margin was 36.43% in FY26.
The stock trades at a PE of 7.58 against an industry PE of 7.16. The dividend yield is 2.59%. In the June 2026 quarter, revenue rose 46.98% to Rs 13,236.10 crore and net profit grew 96.77% to Rs 4,026.83 crore. The share price has gained 183.64% over five years. Domestic institutions raised their holding from 18.41% in June 2025 to 20.14% in June 2026.
Sona BLW: Revenue Up 24.19% in FY26
Sona BLW makes differential gears, motors and drive systems for electric and conventional vehicles for customers around the world. It reported FY26 revenue of Rs 4,572.11 crore, up 24.19% year on year, and net profit of Rs 629.19 crore, up 4.92%. Net profit has compounded at 14.86% a year since FY22, while revenue has grown 20.75% a year. Operating margin was 25.91% in FY26. The debt-to-equity ratio is 0.07, which keeps interest costs low.
In the June 2026 quarter, revenue rose 49.27% to Rs 1,336.07 crore and net profit grew 46.67% to Rs 178.51 crore. The share price is up 70.74% over the past year. Domestic institutions raised their holding from 34.59% in June 2025 to 41.61% in June 2026. The stock trades at a PE of 84.50 against an industry PE of 37.33.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 38.92 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
DII Backed High Margin Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these DII backed high margin stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| MCX | 2,429.05 | 1,331.55 | 100.94% | 53.87% | 74.55% | 77.49% |
| Oil India | 35,877.28 | 7,550.67 | 4.97% | 7.32% | 2.96% | 49.06% |
| Sona BLW | 4,572.11 | 629.19 | 24.19% | 20.75% | 14.86% | 25.23% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% | 30.41% |
Check the Univest Screener for live data on these DII backed high margin stocks
Institutional Holding in MCX, Oil India, Sona BLW and Ajanta Pharma
Institutional holding shows who is backing these DII backed high margin stocks alongside the promoter. The table uses the latest reported quarter for each. MCX has the deepest institutional backing, with FII and DII together holding 80.65% as of June 2026. Domestic institutions increased their holding over the past year in Oil India (from 18.41% to 20.14%), Sona BLW (from 34.59% to 41.61%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| MCX | Nil | 29.84% | 50.81% | 19.34% | June 2026 |
| Oil India | 56.66% | 7.28% | 20.14% | 15.93% | June 2026 |
| Sona BLW | 28.01% | 23.61% | 41.61% | 6.77% | June 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in DII Backed High Margin Stocks
Being careful with DII backed high margin stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Sona BLW trades at a PE of 84.50 against an industry PE of 37.33, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between DII Backed High Margin Stocks
Picking from DII backed high margin stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (7.16 to 42.17) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track MCX, Oil India, Sona BLW and Ajanta Pharma live prices.
Conclusion
Among DII backed high margin stocks, MCX stands out for the highest return on equity at 46.75%, Oil India for the lowest PE of the group at 7.58, Sona BLW for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07 and Ajanta Pharma for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing DII backed high margin stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on DII Backed High Margin Stocks to Watch
Which are the best DII backed high margin stocks to watch for multibagger potential?
Ans. MCX, Oil India, Sona BLW and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 82,566 crore, Rs 72,288 crore, Rs 57,970 crore and Rs 44,167 crore respectively. MCX is notable for the highest return on equity at 46.75%. Oil India stands out for the lowest PE of the group at 7.58. Sona BLW offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07. Ajanta Pharma brings a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.06. These are watchlist names for DII backed high margin stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is MCX a good stock for long-term investors?
Ans. MCX has a return on equity of 46.75%, a PE of 53.55 against an industry PE of 42.17 and a market cap of Rs 82,566 crore. Net profit has compounded at 74.55% a year since FY22, and FY26 revenue rose 100.94% while June 2026 quarter net profit grew 103.47%. Long-term returns in DII backed high margin stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Sona BLW become a multibagger from here?
Ans. Sona BLW has a market cap of Rs 57,970 crore. A multibagger outcome in DII backed high margin stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 14.86% a year since FY22, and FY26 revenue rose 24.19%. At a PE of 84.50 against an industry PE of 37.33, valuation should be checked against that growth before investing.
What is the market cap of MCX, Oil India, Sona BLW and Ajanta Pharma?
Ans. As of 30 October 2026, MCX has a market cap of Rs 82,566 crore, Oil India has a market cap of Rs 72,288 crore, Sona BLW has a market cap of Rs 57,970 crore and Ajanta Pharma has a market cap of Rs 44,167 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on DII backed high margin stocks.
What are the risks of investing in DII backed high margin stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Sona BLW trades at a PE of 84.50 against an industry PE of 37.33, so earnings growth needs to hold up.
Why is Sona BLW trading at a PE of 84.50?
Ans. Sona BLW’s PE of 84.50 compares with an industry PE of 37.33. The market is paying a premium for profit growth of 14.86% a year since FY22, latest-quarter profit growth of 46.67% and FY26 revenue growth of 24.19%, which also means the stock is more sensitive if growth slows. Investors in DII backed high margin stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in MCX, Oil India, Sona BLW and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 80.65% of MCX (29.84% and 50.81%), 27.42% of Oil India (7.28% and 20.14%), 65.22% of Sona BLW (23.61% and 41.61%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in DII backed high margin stocks, though it should be read with earnings trends rather than on its own.
